Clinical Phase I/IIA Study of Subcutaneous Administration of Ofatumumab in Rheumatoid Arthritis Patients on Stable Dose Methotrexate.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Ofatumumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2013 Results published in The Journal of Rheumatology.
- 24 Mar 2012 This trial has been recruiting in France and Spain.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History